In addition, a significant decrease in ileal TNF-α and IL-8 mRNA expression (<i>p</i> < 0.05) and a significant increase in IL-22 (<i>p</i> < 0.05) were observed in the PSE2 treatment compared to the BC group. This evidence concerns the gene CXCL8 and breast cancer.